Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter

Completed · Phase 2

Conditions studied: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter

In brief

RATIONALE: Bortezomib may stop the growth of tumor cells by blocking the enzymes necessary for their growth. PURPOSE: This phase II trial is studying how well bortezomib works in treating patients with advanced or metastatic transitional cell cancer of the bladder, renal pelvis, or ureter.

Key facts

Study ID

NCT00066352

Run by

University Health Network, Toronto

Starts

2003-09-01

Last updated by the study team

2015-07-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Chicago Cancer Research Center — Chicago, Illinois, United States
• Decatur Memorial Hospital Cancer Care Institute — Decatur, Illinois, United States
• CCOP - Evanston — Evanston, Illinois, United States
• Ingalls Cancer Care Center at Ingalls Memorial Hospital — Harvey, Illinois, United States
• Cardinal Bernardin Cancer Center at Loyola University Medical Center — Maywood, Illinois, United States
• Oncology/Hematology Associates of Central Illinois, P.C. — Peoria, Illinois, United States
• Central Illinois Hematology Oncology Center — Springfield, Illinois, United States
• Fort Wayne Medical Oncology and Hematology — Fort Wayne, Indiana, United States
• CCOP - Northern Indiana CR Consortium — South Bend, Indiana, United States
• Oncology Care Associates, P.L.L.C. — Saint Joseph, Michigan, United States
• Medical College of Wisconsin Cancer Center — Milwaukee, Wisconsin, United States
• Margaret and Charles Juravinski Cancer Centre — Hamilton, Ontario, Canada
• London Regional Cancer Program at London Health Sciences Centre — London, Ontario, Canada
• Ottawa Hospital Regional Cancer Centre - General Campus — Ottawa, Ontario, Canada
• Princess Margaret Hospital — Toronto, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.